Article
The 2022 EULAR and ACR Points To Consider At The Earliest Stages Of The Diagnosis And Management Of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Ann Rheum Dis.
(2023)
Abstract
Shakoory B, Geerlinks AV, Wilejto M, Kernan K, Demirkaya E, Ravelli A, Sinha R, Goldbach-Mansky R, De Benedetti F, Marsh R, Canna S. The 2022 EULAR and ACR Points To Consider At The Earliest Stages Of The Diagnosis And Management Of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-1285. PMID: 37487610
Disciplines
Publication Date
October, 2023
Citation Information
Ashley Geerlinks. "The 2022 EULAR and ACR Points To Consider At The Earliest Stages Of The Diagnosis And Management Of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)." Ann Rheum Dis. (2023) Available at: http://works.bepress.com/ashley-geerlinks/6/